Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Long-term effects of neurofeedback treatment for ADHD

Neu­ro­feed­back — also known as EEG Biofeed­back — is an approach for treat­ing ADHD in which indi­vid­u­als are pro­vid­ed real-time feed­back on their brain­wave pat­terns and taught to pro­duce and main­tain pat­terns con­sis­tent with a focused, atten­tive state. This is often done by col­lect­ing brain­wave, i.e., EEG, data from indi­vid­u­als as they focus on stim­uli pre­sent­ed on a com­put­er screen. Their abil­i­ty to con­trol the stim­uli, for exam­ple, keep­ing the ‘smile on a smi­ley face’, is con­tin­gent on main­tain­ing the brain­wave pat­tern being trained.

Neu­ro­feed­back sup­port­ers believe that learn­ing this dur­ing train­ing gen­er­al­izes to real world sit­u­a­tions and results in improved atten­tion and reduced hyperactive/impulsive behav­ior. Although a num­ber of neu­ro­feed­back stud­ies have yield­ed promis­ing results it remains some­what con­tro­ver­sial with some researchers argu­ing that lim­i­ta­tions of these stud­ies pre­clude firm con­clu­sions about the effec­tive­ness of neu­ro­feed­back from being drawn.

Last year I reviewed a par­tic­u­lar­ly well-con­duct­ed study of neu­ro­feed­back treat­ment for ADHD — see my review here. The study was con­duct­ed in Ger­many and began with 94 chil­dren aged 8 to 12. All had been care­ful­ly diag­nosed with ADHD and over 90% had nev­er received med­ica­tion treat­ment. About 80% were boys.

Chil­dren were ran­dom­ly assigned to receive either 36 ses­sions of neu­ro­feed­back train­ing or 36 ses­sions of com­put­er­ized atten­tion train­ing. The com­put­er­ized atten­tion train­ing task was intend­ed to serve as the con­trol inter­ven­tion and pro­vid­ed equal amounts of time work­ing on a demand­ing cog­ni­tive task under the super­vi­sion of an adult; the inclu­sion of this con­trol con­di­tion is a real strength of the study.

The main find­ings were as fol­lows:

1. Par­ents of chil­dren treat­ed with neu­ro­feed­back report­ed sig­nif­i­cant­ly greater reduc­tions in inat­ten­tive and hyper­ac­tive-impul­sive symp­toms than par­ents of con­trol chil­dren, i.e,. those who received com­put­er­ized atten­tion train­ing. The size of the group dif­fer­ence was in a range that would be con­sid­ered mod­er­ate, i.e., about .5 stan­dard devi­a­tions. 2. Teach­ers of chil­dren treat­ed with neu­ro­feed­back report­ed sig­nif­i­cant­ly greater reduc­tions in inat­ten­tive and hyper­ac­tive-impul­sive symp­toms than teach­ers of con­trol chil­dren. The size of the group dif­fer­ence was sim­i­lar to that found for par­ents, about .5 stan­dard devi­a­tions.

The authors also exam­ined the per­cent­age of chil­dren in each group that were judged to derive a ‘sig­nif­i­cant’ ben­e­fit, defined as at least a 25% reduc­tion in core ADHD symp­toms. Fifty-one per­cent of chil­dren in the neu­ro­feed­back group met this thresh­old com­pared to only 26% of chil­dren in the atten­tion train­ing con­trol group. This dif­fer­ence was sta­tis­ti­cal­ly sig­nif­i­cant.

- New study presents 6-month fol­low-up results -

Recent­ly, the authors of this study pub­lished 6-month fol­low-up data so that the dura­tion of neu­ro­feed­back treat­ment effects could be exam­ined. This is an impor­tant issue to study as one of the pur­port­ed ben­e­fits of neu­ro­feed­back treat­ment is that the effects can endure well beyond when treat­ment has been com­plet­ed.

Fol­low-up data was avail­able on 61 of the orig­i­nal par­tic­i­pants includ­ing 38 from the neu­ro­feed­back group and 23 from the con­trol group. Fol­low-up data was based on par­ents rat­ings only as teacher rat­ings were not obtained at this time point.

Of the 32 ‘drop outs’, par­ents of 15 did not return the fol­low-up rat­ing scales while the remain­ing 17 had start­ed on med­ica­tion. Chil­dren who began med­ica­tion were not includ­ed because it was not pos­si­ble to deter­mine the extent to which their cur­rent func­tion­ing reflect­ed their ini­tial treat­ment or their cur­rent med­ica­tion. How­ev­er, it is rea­son­able to assume that par­ents would only start med­ica­tion if they were not sat­is­fied with how their child was doing.

- Results -

Key find­ings were as fol­lows.

1. Par­ents’ rat­ings of core ADHD symp­toms indi­cat­ed that chil­dren treat­ed with neu­ro­feed­back were still doing sig­nif­i­cant­ly bet­ter than chil­dren who received the ‘con­trol treat­ment’. The mag­ni­tude of the dif­fer­ence was mod­er­ate to large, i.e., about .7 stan­dard devi­a­tions. Reduc­tions in symp­toms scores from the ini­tial base­line rat­ings were in the range of 25–30% for the neu­ro­feed­back group com­pared to only 10–15% for the con­trol group.

2.Children in the neu­ro­feed­back tend­ed to receive low­er rat­ings for delin­quent and phys­i­cal­ly aggres­sive behav­ior, but these dif­fer­ences did not quite reach sta­tis­ti­cal sig­nif­i­cance.

3. Par­ents’ reports of home­work dif­fi­cul­ties showed a greater decline over time for the neu­ro­feed­back treat­ed chil­dren than for con­trol chil­dren.

4. Group dif­fer­ences in a range of prob­lem­at­ic sit­u­a­tions that occur at home were not sig­nif­i­cant.

In addi­tion to these analy­ses, the researchers also com­put­ed the per­cent­age of chil­dren in each group who were con­sid­ered to show a good treat­ment response, defined as at least a 25% reduc­tion in par­ents’ rat­ings of core ADHD symp­toms com­pared to base­line. This was true for 50% of chil­dren in the NF group com­pared to 30% of those in the con­trol group. These dif­fer­ences were in the expect­ed direc­tion but did not quite reach sta­tis­ti­cal sig­nif­i­cance giv­en the rel­a­tive small sam­ple size at fol­low-up, i.e., a total of only 61 chil­dren.

- Sum­ma­ry and Impli­ca­tions -

Results indi­cate that the ben­e­fits of neu­ro­feed­back treat­ment were main­tained 6 months after treat­ment had end­ed. Thus, com­pared to chil­dren who received com­put­er­ized atten­tion train­ing, which served as the con­trol treat­ment, neu­ro­feed­back treat­ed chil­dren con­tin­ued to receive sig­nif­i­cant­ly low­er par­ent rat­ings of core ADHD symp­toms and also showed a greater decline in home­work dif­fi­cul­ties over time. These are encour­ag­ing find­ings and high­light that neu­ro­feed­back can be a ben­e­fi­cial treat­ment for some chil­dren with ADHD.

Despite these pos­i­tive find­ings, how­ev­er, it is impor­tant to empha­size that only 50% of chil­dren treat­ed with neu­ro­feed­back showed at least a 25% decline in core ADHD symp­toms at 6 months, mean­ing that the oth­er 50% failed to show this lev­el of clin­i­cal response. And, if one assumes that many of the chil­dren who began med­ica­tion were also like­ly to have been non-respon­ders (pre­sum­ably par­ents would not have start­ed med­ica­tion oth­er­wise), this fig­ure becomes even high­er. In addi­tion, no fol­low-up data from teach­ers was avail­able so it is not pos­si­ble to know the extent to which any ben­e­fi­cial effects were main­tained at school.

In recog­ni­tion of these treat­ment lim­i­ta­tions, the authors con­clude that “…the low respon­der rate and the por­tion of chil­dren start­ing a med­ica­tion in our study argue against NF as a stand-alone inter­ven­tion for ADHD. The results indi­cate that not every child with ADHD may improve after NF treat­ment. In our opin­ion, NF should rather be seen as a treat­ment mod­ule for chil­dren with ADHD which can be embed­ded in a mul­ti­modal treat­ment pro­gram tai­lored to the indi­vid­ual needs of the child.”

The authors also not­ed, how­ev­er, that because they fol­lowed a stan­dard­ized treat­ment pro­to­col for research pur­pos­es, rather than care­ful­ly tai­lor­ing neu­ro­feed­back treat­ment to each child, that their results may under­es­ti­mate what is obtained in actu­al clin­i­cal sit­u­a­tions.

In con­clu­sion, results from this fol­low-up study pro­vide evi­dence that neu­ro­feed­back can yield endur­ing ben­e­fits for some chil­dren with ADHD. As sug­gest­ed by the authors, it may be an impor­tant com­po­nent of a mul­ti­modal treat­ment pro­gram but its con­sis­tent use as a stand alone treat­ment does not seem to be sup­port­ed by the find­ings report­ed here.

Rabiner_David– Dr. David Rabin­er is a child clin­i­cal psy­chol­o­gist and Direc­tor of Under­grad­u­ate Stud­ies in the Depart­ment of Psy­chol­ogy and Neu­ro­science at Duke Uni­ver­sity. He pub­lishes Atten­tion Research Update, an online newslet­ter that helps par­ents, pro­fes­sion­als, and edu­ca­tors keep up with the lat­est research on ADHD, and teach­es the online course  How to Nav­i­gate Con­ven­tion­al and Com­ple­men­tary ADHD Treat­ments for Healthy Brain Devel­op­ment.

Relat­ed arti­cles by Dr. Rabin­er:

Leave a Reply...

Loading Facebook Comments ...

3 Responses

  1. Kevin says:

    This is a great arti­cle. I’m very impressed.
    Thanks
    Kevin

  2. Madhu says:

    Hi,

    I just want­ed to let you know that I’ve includ­ed this post in the lat­est Sci­en­tia Pro Pub­li­ca now up over on my blog. Do drop by when you have a moment.

    thanks,

    Mad­hu

  3. Nelly says:

    Hel­lo,

    I think it is amaz­ing that some­thing that was used only for 40 sessions(aprox.2 or 3 months) and after six months with­out receiv­ing any med­ica­tion or ther­a­py have shown some reduc­tion in symp­tons in some chil­dren with ADHD. Have many med­ica­tions or ther­a­py you know that it can do that after tak­ing them or hav­ing ther­a­py.

    This is some­thing I found and it talks about the research made with med­ica­tion and ther­a­py that the NIHM did with ADHD.I belive it was one of the longest study.
    “What the MTA real­ly showed is that it’s not the med­ica­tion per se but the inten­sive mon­i­tor­ing,” says Benedet­to Vitiel­lo, chief of the child and ado­les­cent treat­ment and pre­ven­tive inter­ven­tions branch for the Nation­al Insti­tute of Men­tal Health. “Hav­ing a vis­it each month, putting togeth­er all the infor­ma­tion for the school and the par­ent, tai­lor­ing the treat­ment.” Indeed, when the study end­ed and the extra mon­i­tor­ing stopped, the ben­e­fits fad­ed for all groups, med­icat­ed or not.

    Medicines(if you tol­er­ate the sec­ondary effects) take years and when you stop tak­ing them you con­tin­ue hav­ing some adhd symptoms(in most adults they con­tin­ue with the symptoms.I have ADD.New tech­nol­o­gy is show­ing that our brain works dif­fer­ent.

    It will have been great to know what hap­pen in the brain of those kids who have some changes in their behav­iors.

    In the ones who took med­ica­tion maybe they need­ed more ses­sions. They should done a study show­ing have many ses­sion are need­ed.

    This is impor­tant because even when you med­icate some­one. Peo­ple who do not always react well to the same dosage.

    What machine they use for the study. Some machines do not have imped­ance check. Which mean that they can be mea­sur­ing some­thing else and not your brain­waves. Did they do a QEEG? In some peo­ple the brain­waves asso­ci­at­ed with ADHD are not in the same area of the head or they shown them in dif­fer­ent areas. This means that if you are work­ing the wrong area it may not help them.

    It think it will be great to do a fol­low about after a longer peri­od of time to see what hap­pen with those chil­dren who showns some decrease.

    I apol­o­gized for my Eng­lish but it is not my lan­guage nor do I live in USA.

    Thanks,
    Nel­ly

Leave a Reply

Categories: Attention and ADD/ADHD, Cognitive Neuroscience, Education & Lifelong Learning

Tags: , , , , , , , , , , , , , , , , ,

All Slidedecks & Recordings Available — click image below

Search for anything brain-related in our article archives

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters, and more, SharpBrains is an independent market research firm and think tank tracking health and performance applications of brain science.